These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21119150)

  • 41. Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.
    Sapra M; Vahia IV; Reyes PN; Ramirez P; Cohen CI
    Schizophr Res; 2008 Dec; 106(2-3):348-55. PubMed ID: 18851906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study.
    Bäuml J; Pitschel-Walz G; Volz A; Lüscher S; Rentrop M; Kissling W; Jahn T
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S62-70. PubMed ID: 26955982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
    Morrissette DA; Stahl SM
    CNS Spectr; 2012 Nov; 17 Suppl 1():10-21. PubMed ID: 23462201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
    Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?
    Moran K; Priebe S
    Qual Life Res; 2016 Aug; 25(8):1897-902. PubMed ID: 26850023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
    Ascher-Svanum H; Weiden P; Nyhuis AW; Faries DE; Stauffer V; Kollack-Walker S; Kinon BJ
    Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):84-90, 90A. PubMed ID: 23446198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term management of schizophrenic disorders].
    Canceil O
    Encephale; 2007 Jun; 33 Pt 3():S395-8. PubMed ID: 19101358
    [No Abstract]   [Full Text] [Related]  

  • 50. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.
    Bodén R; Brandt L; Kieler H; Andersen M; Reutfors J
    Schizophr Res; 2011 Dec; 133(1-3):36-41. PubMed ID: 21982098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.
    Czobor P; Van Dorn RA; Citrome L; Kahn RS; Fleischhacker WW; Volavka J
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1158-66. PubMed ID: 26004980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder.
    Quach PL; Mors O; Christensen TØ; Krarup G; Jørgensen P; Bertelsen M; Jeppesen P; Petersen L; Thorup A; Nordentoft M
    Early Interv Psychiatry; 2009 Feb; 3(1):66-74. PubMed ID: 21352177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O; Tranulis C
    Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Risk factors for treatment adherence in patients with schizophrenia: case-control study].
    Aarab C; Elghazouani F; Aalouane R; Rammouz I
    Pan Afr Med J; 2015; 20():273. PubMed ID: 26161196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis.
    Uhlmann C; Kaehler J; Harris MS; Unser J; Arolt V; Lencer R
    J Psychiatr Pract; 2014 Sep; 20(5):405-10. PubMed ID: 25226204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of perceived social support on medication adherence in first-episode psychosis.
    Rabinovitch M; Cassidy C; Schmitz N; Joober R; Malla A
    Can J Psychiatry; 2013 Jan; 58(1):59-65. PubMed ID: 23327758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
    Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
    J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.